background image

Pancreatic Cancer Clinical Trials

Find clinical trials for pancreatic cancer. Search for pancreatic cancer clinical trials in different cities and states across the United States.

Filter
1
Active & ResponsiveNew

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

for
Prostate Cancer Castration-resistant Prostate Cancer,
Location: Grand Rapids MI, Irving TX, San Antonio TX,
Sponsor: MBrace Therapeutics

Sex: All

Age: 18+

Code: NCT07145255

Phase1, Phase2, Recruiting
Active & ResponsiveNew

Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis

for
Pancreatic Insufficiency, Cystic Fibrosis-related Diabetes
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 18+

Code: NCT06995651

Phase1, Recruiting
Active & ResponsiveNew

Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)

for
Cystic Fibrosis
Location: Birmingham AL, Aurora CO, Denver CO, Wilmington DE,
Sponsor: Boston Children's Hospital

Sex: All

Age: 6+

Code: NCT06683092

Recruiting
Active & ResponsiveNew

Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy

for
Cystic Fibrosis (CF), Chronic Rhinosinusitis (CRS)
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT06996951

Phase3, Recruiting
Active & ResponsiveNew

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Fairfax VA
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07111520

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & ResponsiveNew

Investigation of Lymph Node Biology in Kidney Cancer

for
Renal Cell Carcinoma (RCC)
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07038733

Recruiting
Active & ResponsiveNew

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Los Angeles CA, Palo Alto CA, San Francisco CA,
Sponsor: TuHURA Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT06947928

Phase2, Phase3, Recruiting
Active & ResponsiveNew

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

for
Acute Biphenotypic Leukemia, Acute Leukemia,
Location: Los Angeles CA, Iowa City IA, Cleveland OH, Portland OR,
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 0 - 26

Code: NCT03779854

Phase2, Recruiting
Active & ResponsiveNew

Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma

for
Skin Basal Cell Carcinoma, Skin Nodular Basal Cell Carcinoma,
Location: Columbus OH
Sponsor: Brittany Dulmage

Sex: All

Age: 18+

Code: NCT07144384

Early_phase1, Recruiting
Active & ResponsiveNew

A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

for
HLA-A*0201 Positive Cells Present, Clear Cell Sarcoma (CCS)
Location: New York NY
Sponsor: Sarcoma Alliance for Research through Collaboration

Sex: All

Age: 18+

Code: NCT06942442

Phase2, Recruiting